Mouse Anti-HAS2 Monoclonal Antibody (4E7) (CBMAB-1352-YC)

Name: Mouse Anti-HAS2 Monoclonal Antibody (4E7)
SKU: CBMAB-1352-YC
Rating: 5 (1 reviews)

See all HAS2 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

4E7

Application

IHC-P, ICC, IF, FC, WB

Immunogen

Purified recombinant fragment, corresponding to aa 67-170 of Human Hyaluronan synthase 2, expressed in E. coli.

Specificity

Human

Antibody Isotype

IgG1

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Storage

Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Hyaluronan Synthase 2

Introduction

HAS2 is a member of the newly identified vertebrate gene family encoding putative hyaluronan synthases, and its amino acid sequence shows significant homology to glycosaminoglycan synthetase (DG42) from Xenopus laevis, and human and murine hyaluronan synthase 1.

Entrez Gene ID

3037

UniProt ID

Q92819

Alternative Names

HA synthase 2; hyaluronic acid synthase 2; hyaluronate synthase 2; EC 2.4.1.212

Function

Catalyzes the addition of GlcNAc or GlcUA monosaccharides to the nascent hyaluronan polymer. Therefore, it is essential to hyaluronan synthesis a major component of most extracellular matrices that has a structural role in tissues architectures and regulates cell adhesion, migration and differentiation. This is one of the isozymes catalyzing that reaction and it is particularly responsible for the synthesis of high molecular mass hyaluronan. Required for the transition of endocardial cushion cells into mesenchymal cells, a process crucial for heart development. May also play a role in vasculogenesis. High molecular mass hyaluronan also play a role in early contact inhibition a process which stops cell growth when cells come into contact with each other or the extracellular matrix (By similarity).

Biological Process

Atrioventricular canal development Source: UniProtKB
Bone morphogenesis Source: Ensembl
Cellular response to fluid shear stress Source: BHF-UCL
Cellular response to interleukin-1 Source: BHF-UCL
Cellular response to platelet-derived growth factor stimulus Source: UniProtKB
Cellular response to tumor necrosis factor Source: BHF-UCL
Endocardial cushion to mesenchymal transition Source: UniProtKB
Estrous cycle Source: Ensembl
Extracellular matrix assembly Source: UniProtKB
Extracellular polysaccharide biosynthetic process Source: UniProtKB
Hyaluronan biosynthetic process Source: UniProtKB
Kidney development Source: UniProtKB
Positive regulation of cell migration Source: BHF-UCL
Positive regulation of cell population proliferation Source: BHF-UCL
Positive regulation of hyaluronan biosynthetic process Source: Ensembl
Positive regulation of keratinocyte migration Source: Ensembl
Positive regulation of keratinocyte proliferation Source: Ensembl
Positive regulation of monocyte aggregation Source: BHF-UCL
Positive regulation of smooth muscle cell migration Source: Ensembl
Positive regulation of substrate adhesion-dependent cell spreading Source: Ensembl
Positive regulation of urine volume Source: UniProtKB
Regulation of extracellular matrix assembly Source: Ensembl
Renal water absorption Source: UniProtKB
Vasculogenesis Source: UniProtKB

Cellular Location

Membrane

Involvement in disease

A chromosomal aberration involving HAS2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. 8q12.1 to 8q24.1 intrachromosomal rearrangement with PLAG1.

Topology

Cytoplasmic: 1-11
Helical: 12-32
Extracellular: 33-45
Helical: 46-66
Cytoplasmic: 67-374
Helical: 375-395
Extracellular: 396-402
Helical: 403-423
Cytoplasmic: 424-429
Helical: 430-450
Extracellular: 451-475
Helical: 476-496
Cytoplasmic: 497-510
Helical: 511-531
Extracellular: 532-552

Kim, S. M., Song, G. Y., Shim, A., Lee, J. H., Eom, C. B., Liu, C., ... & Seki, E. (2022). Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4. Experimental & molecular medicine, 54(6), 739-752.

Sheng, Y., Cao, M., Liu, Y., He, Y., Zhang, G., Du, Y., ... & Yang, C. (2021). Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells. Molecular and Cellular Biochemistry, 476(9), 3383-3391.

Caon, I., Bartolini, B., Moretto, P., Parnigoni, A., Caravà, E., Vitale, D. L., ... & Vigetti, D. (2020). Sirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-κB and expression of the long-noncoding RNA HAS2–AS1. Journal of Biological Chemistry, 295(11), 3485-3496.

Li, H., Guo, H., Lei, C., Liu, L., Xu, L., Feng, Y., ... & Long, X. (2019). Nanotherapy in joints: increasing endogenous hyaluronan production by delivering hyaluronan synthase 2. Advanced Materials, 31(46), 1904535.

de Mera, R. M. F., Arasu, U. T., Kärnä, R., Oikari, S., Rilla, K., Vigetti, D., ... & Deen, A. J. (2019). Effects of mutations in the post-translational modification sites on the trafficking of hyaluronan synthase 2 (HAS2). Matrix Biology, 80, 85-103.

Ishizuka, S., Tsuchiya, S., Ohashi, Y., Terabe, K., Askew, E. B., Ishizuka, N., ... & Knudson, W. (2019). Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan. Journal of Biological Chemistry, 294(37), 13562-13579.

Yang, Y. M., Noureddin, M., Liu, C., Ohashi, K., Kim, S. Y., Ramnath, D., ... & Seki, E. (2019). Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Science translational medicine, 11(496), eaat9284.

Rauhala, L., Jokela, T., Kärnä, R., Bart, G., Takabe, P., Oikari, S., ... & Tammi, R. H. (2018). Extracellular ATP activates hyaluronan synthase 2 (HAS2) in epidermal keratinocytes via P2Y2, Ca2+ signaling, and MAPK pathways. Biochemical Journal, 475(10), 1755-1772.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-HAS2 Monoclonal Antibody (4E7)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-HAS2 (AA 67-170) Recombinant Antibody (CBFYH-0710) (CAT#: CBMAB-H1599-FY)

Mouse Anti-HAS2 Recombinant Antibody (CBT2439) (CAT#: V2LY-0625-LY2811)

Mouse Anti-HAS2 Recombinant Antibody (CBFYH-0711) (CAT#: CBMAB-H1600-FY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry